InforSense Signs Distribution Agreement with CTC Laboratory Systems Corporation
News Jun 02, 2006
InforSense’s workflow-based integrative analytics environment, InforSense® KDE, is designed to enable enterprises in the life science and healthcare domains to create, integrate and leverage decision making knowledge more effectively.
CTCLS will provide local marketing and support for the latest versions of InforSense’s informatics platform in the growing Japanese marketplace.
"We are delighted to be able to work with InforSense as we see their leading workflow-based technology fulfilling an unmet need for many Japanese life science and healthcare companies," said Taizo Watanabe, President of CTC Laboratory Systems Corporation.
"With InforSense KDE, scientists and informaticians can make better use of existing investments in data and software tools to support their business decisions and processes."
"InforSense is experiencing strong demand for its products within the Japanese marketplace and we welcome CTC as our partner in bringing our technology to a wider customer-base," said Joseph F. Donahue, Chief Business Officer of InforSense.
"Their established relationships with many companies within the life science and healthcare domains should prove invaluable as InforSense grows its user-base in Japan."
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu VaccineNews
Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, announces that Innovate UK, the UK’s innovation agency, has awarded the company a grant of £979,318 to progress its universal flu vaccine programme through preclinical development.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018